Lumi™ Drug Scan shortlisted for KiwiNet Award
ESR's Lumi™ Drug Scan has been shortlisted for a prestigious KiwiNet Research Commercialisation Impact Award.
The shortlisting comes hot off the heels of Lumi™ winning the Excellence in Forensic Science Award(external link) at the 2023 World Police Summit in March, and is further validation of the difference this game-changing illicit drug detection service is making to communities.
Lumi™ brings together the power of a lightweight device that can scan for traces of cocaine, MDMA and methamphetamine using infrared lights, giving instantaneous results via Bluetooth to the powerful Lumi™ mobile app. These insights are also available in the sophisticated Lumi™ dashboard, which charts regional drug trends.
With 18 finalists in total, the 2023 KiwiNet Awards will be announced in Auckland on 28 September. The other finalists in the MAS Commercialisation Impact Award category are:
- TDRIand Lincoln Agritech: Reducing roading costs with rapid subsurface moisture detection
- XFrame and Wellington UniVentures: Reusable framing for the next generation of sustainable construction.
You can find out more on KiwiNet's website(external link).
Lumi™ has been co-developed by New Zealand Police.
The Ministry of Business, Innovation, and Employment’s Strategic Science Investment Fund (SSIF) has provided invaluable funding to this project. SSIF enables the prioritisation and purchase of science in areas that ensure the long-term stability and impact of the science system.
